News
Portfolio Company News
- September 01, 2010
Pfizer Agrees To Buy FoldRx in Rare-Disease Treatment Expansion Effort
- August 30, 2010
Trevena / FierceBiotech's Top 10 Women in Biotech
- August 30, 2010
UPDATE 1-Novartis, Portola heart drug moves to final tests - August 30, 2010
Achaogen Awarded Contract Worth up to $64 Million by BARDA for the Development of ACHN-490
- August 27, 2010
Plexxikon Drug Delivers Strong Results From Melanoma Study - August 26, 2010
Swedish Orphan Biovitrum's Kineret® has Received Orphan Drug Designation in the USA
- August 23, 2010
Taligen Set To Enter Clinic After Securing $10M Series B Tranche - August 12, 2010
Aegerion Re-Files $86M IPO to Back Cholesterol Drug
- August 09, 2010
aTyr's fresh biology - August 03, 2010
Excaliard Announces Positive Data From Phase 2 Clinical Trial Of Its Anti‐Scarring Drug, EXC 001 - July 29, 2010
Astex scientists describe novel HSP90 inhibitors in two key publications in Journal of Medicinal Chemistry
- July 27, 2010
Immune Design To Advance Vaccines Pipeline With $32M Series B - July 27, 2010
Cerenis Therapeutics raises EUR 40 Million in Series C Financing
- July 27, 2010
Immune Design Nabs $32M for Targeted Vaccines
- July 26, 2010
Cerenis Therapeutics Hauls In $51M For HDL Drug Trials - July 26, 2010
Cytokinetics Announces Award of Grant for Preclinical and Clinical Development of CK-2017357 in Myasthenia Gravis
- July 22, 2010
Cytokinetics Announces Presentation of Phase I Data Relating to CK-2017357 at the XII International Congress on Neuromuscular Diseases
- July 20, 2010
Kiadis Pharma receives IND approval from FDA to start pivotal clinical trial with ATIR™
- July 14, 2010
Trevena Secures $35 Million in Series B Funding - July 12, 2010
Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the World Federation of Hemophilia Congress
< Previous
